Supplemental Filings: Gene Therapy Harmonization Moving Ahead; US FDA’s COVID-19 EUA Authority Hanging Around
Executive Summary
Peter Marks suggests the need for a ‘compromise’ on gene therapy. Elizabeth Sadove looks towards an extended tenure for COVID products under EUAs.